FIELD: medicine.
SUBSTANCE: method involves carrying out radical operation in combination with intra-operative radiation therapy at a dose of 15 Gray per removed tumor bed and regional metastasis path. The operation combined with intra-operative radiation therapy is done in 3 weeks after finishing polychemotherapy composed of at least 2 courses to reach positive result of tumor reduction more than 75%. Pause between the courses is 3 weeks long. Following scheme is administered: Hemcytabin 1250 mg/m2 in intravenous drop-by-drop introduction during half-an-hour long infusion at the second and the ninth day, Cisplatin 50 mg/m2 is introduced at the first and the eighth day.
EFFECT: stopped progressive tumor development; prevented metastases formation.
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATMENT OF PATIENTS WITH LOCAL NON-SMALL CELL LUNG CANCER | 2007 |
|
RU2361580C2 |
METHOD OF COMBINATION TREATMENT OF PATIENTS WITH LOCALLY ADVANCED OPERABLE OESOPHAGEAL CANCER | 2009 |
|
RU2424007C1 |
METHOD OF COMBINED TREATMENT OF NON-SMALL CELL CANCER OF LUNG OF III STAGE | 2007 |
|
RU2340336C1 |
METHOD OF COMBINED TREATMENT OF PATIENTS WITH LOCALLY SPREAD RESECTABLE ESOPHAGEAL CANCER | 2009 |
|
RU2419391C1 |
METHOD OF COMBINED TREATMENT OF LUNG CANCER STAGE III | 2007 |
|
RU2348440C2 |
COMBINATION THERAPY OF LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER | 2007 |
|
RU2372901C2 |
METHOD OF COMBINATION TREATMENT OF STAGE IIIA-IIIB LOCALLY ADVANCED NON-SMALL-CELL LUNG CANCER | 2010 |
|
RU2431450C1 |
METHOD FOR PREVENTION OF POSTOPERATIVE COMPLICATIONS OF COMBINED TREATMENT OF PATIENTS WITH STAGE III NON-SMALL-CELL LUNG CANCER | 2010 |
|
RU2429842C1 |
MARKING PROCEDURE FOR INTRAOPERATIVE RADIATION THERAPY TARGET WITHIN COMBINED TREATMENT OF LUNG CANCER OF TH | 2007 |
|
RU2348357C1 |
METHOD OF COMBINED TREATMENT OF NON-SMALL CELL LUNG CANCER OF II AND III STAGE | 2011 |
|
RU2455986C1 |
Authors
Dates
2006-02-27—Published
2004-04-05—Filed